QP

Qinglin Pu

Merck: 4 patents #36 of 909Top 4%
IP Iomet Pharma: 1 patents #3 of 11Top 30%
Overall (2021): #42,100 of 548,734Top 8%
4
Patents 2021

Issued Patents 2021

Patent #TitleCo-InventorsDate
11096930 Substituted imidazopyridine compounds as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan-2,3-dioxygenase Phillip M. Cowley, Meredeth A. McGowan, Thomas J. Brown, Yongxin Han, Kun Liu +3 more 2021-08-24
11034661 Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase IDO inhibitors Liangqin Guo, Yongxin Han, Kun Liu, Shuwen He, Joseph A. Kozlowski +6 more 2021-06-15
10988487 Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Kun Liu, Abdelghani Achab, Purakkattle Biju, Timothy A. Cernak, Yongqi Deng +10 more 2021-04-27
10927086 Substituted sulfoximine compounds as indoleamine 2,3-dioxygenase (IDO) inhibitors Kun Liu, Dane Clausen, Liangqin Guo, Yongxin Han, Shuwen He +4 more 2021-02-23